Valuation: Bayer AG

Market Cap 54.96B 60.26B 50.81B 45.86B 86.36B 5,631B 89.77B 614B 243B 3,039B 226B 221B 9,598B P/E 2026 *
25x
P/E 2027 * 18.5x
Enterprise Value 84.72B 92.9B 78.34B 70.69B 133B 8,681B 138B 946B 374B 4,686B 349B 341B 14,796B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.73x
Free-Float
100%
Yield 2026 *
0.25%
Yield 2027 * 0.95%
1 day-0.63%
1 week-1.77%
Current month+9.85%
1 month+28.02%
3 months+13.36%
6 months+44.24%
Current year+50.12%
1 week 55.4
Extreme 55.4
57.38
1 month 43.08
Extreme 43.08
57.84
Current year 32.96
Extreme 32.96
57.84
1 year 26.64
Extreme 26.64
57.84
3 years 18.38
Extreme 18.378
57.84
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 69 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Buy

Director

1,900 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-1.77%+105.63%+63.39% 60.26B
-2.32%-3.79%+34.24%+133.69% 1,232B
-2.15%-2.75%+36.35%+82.05% 656B
-2.33%-3.04%+22.29%+106.80% 506B
-0.73%-1.67%+28.85%+68.54% 382B
-3.90%-6.39%+42.88%+35.41% 340B
-2.91%-5.05%+24.67%+51.21% 294B
-1.43%-3.45%-1.07%+33.09% 278B
-3.07%-5.17%+29.04%+67.26% 240B
-0.75%-0.44%+32.87%+123.96% 210B
Average -0.80%-2.22%+35.58%+76.54% 420B
Weighted average by Cap. -0.71%-2.65%+30.99%+90.75%

Financials

2026 *2027 *
Net sales 45.96B 50.4B 42.5B 38.35B 72.23B 4,710B 75.08B 513B 203B 2,542B 189B 185B 8,027B 47.22B 51.77B 43.66B 39.4B 74.2B 4,838B 77.12B 527B 208B 2,611B 194B 190B 8,246B
Net income 2.19B 2.4B 2.02B 1.83B 3.44B 224B 3.58B 24.45B 9.67B 121B 9.01B 8.82B 382B 2.91B 3.19B 2.69B 2.43B 4.58B 298B 4.76B 32.52B 12.85B 161B 11.98B 11.73B 509B
Net Debt 29.77B 32.64B 27.52B 24.84B 46.78B 3,050B 48.62B 332B 131B 1,646B 122B 120B 5,199B 26.66B 29.24B 24.65B 22.25B 41.9B 2,732B 43.55B 298B 118B 1,475B 110B 107B 4,656B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,775
Date Price Change Volume
19/11/26 €55.60 -0.61% 614,364
18/11/26 €55.94 -0.36% 2,161,895
17/11/26 €56.14 -1.51% 1,978,746
16/11/26 €57.00 +0.85% 2,090,516
13/11/26 €56.52 -0.07% 1,893,501
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
55.94EUR
Average target price
60.58EUR
Spread / Average Target
+8.30%
  1. Stock Market
  2. Stocks
  3. BAYN Stock